Sartorius Finance BV
Sartorius Finance BV is a specialized financing subsidiary and debt-issuing vehicle for Sartorius AG, a leading German life science research and biopharmaceutical equipment group. The company issues corporate bonds and debt instruments in European capital markets to fund the capital structure, strategic acquisitions, and refinancing requirements of Sartorius operating entities worldwide. Sartorius AG is a major global provider of laboratory instruments, bioprocess solutions, filtration systems, and fermentation technologies used by pharmaceutical companies and research institutes. Cash flows servicing Sartorius Finance's debt obligations are derived directly from intercompany loan repayments funded by the robust operating cash flows of Sartorius's global life science business. Sartorius holds a dominant global market position in biopharmaceutical manufacturing technology and laboratory equipment. Sartorius Finance BV is headquartered in Amsterdam, Netherlands.
6 of the funds FundTelligence covers report a position in Sartorius Finance BV.
- Legal name
- SARTORIUS FINANCE BV
- Sector
- Financials
- Country
- Netherlands
- Funds holding it
- 6
Funds holding Sartorius Finance BV
- Danske Invest Euro Investment Grade Corporate Bond — Danske Invest · 1.08 % (full portfolio disclosed, September 2026)
- Danske Invest European Corporate Sustainable Bond — Danske Invest · 0.57 % (full portfolio disclosed, September 2026)
- Mercer Short Duration Global Bond Fund 2 — Mercer · 0.23 % (full portfolio disclosed, December 2025)
- Mercer Short Duration Global Bond Fund 1 — Mercer · 0.14 % (full portfolio disclosed, December 2025)
- Nordea Euro Corporate Enhanced Bond Fund — Nordea Funds · 0.04 % (full portfolio disclosed, July 2026)
- KLP Obligasjon Global 3 år — KLP · 0.04 % (full portfolio disclosed, June 2026)